Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Clin Cancer Res. 2012 Feb 28;18(9):2638–2647. doi: 10.1158/1078-0432.CCR-11-3203

Table 4.

Flavopiridol pharmacokinetics by dose level during cycle 1.

Cohort Doxo Flavo n Mean Cmax (uM) Standard Deviation (SD)
1 60 40 3 2.27 0.49
2 60 50 3 2.23 0.52
3 60 60 3 3.29 1.39
4 60 70 3 2.22 0.07
5 75 60 3 2.46 0.67
6 60 70 (40/30) 4 2.56 0.31
7 60 80 (50/30) 6 3.03 1.29
8 60 90 (50/40) 4 3.33 1.38